title: Transient light-sensitivity syndrome after laser in situ keratomileusis with the femtosecond laser Incidence and prevention.
abstract: OBJECTIVE
  To describe the incidence of transient light-sensitivity syndrome (TLSS) after laser in situ keratomileusis (LASIK) with the femtosecond laser and to identify preventive strategies.
  
  
  METHODS
  Hospital NISA Virgen del Consuelo, Valencia, Spain.
  
  
  METHODS
  The first 765 eyes operated on with the 15 KHz femtosecond laser were prospectively analyzed for subjective complaints and clinical findings compatible with TLSS. Intraoperative settings, postoperative treatment, and development of complications were analyzed.
  
  
  RESULTS
  Overall, TLSS developed in 10 eyes (incidence 1.3%). However, the incidence decreased from 2.8% to 0.4% when aggressive topical steroids were used during the first 3 postoperative days. Postoperative interface inflammation and postoperative use of a low-dose topical steroid regimen were associated with a higher incidence of TLSS.
  
  
  CONCLUSIONS
  Transient light-sensitivity syndrome is a relatively uncommon complication related to the use of the femtosecond laser. Postoperative interface inflammation may increase the probability of developing TLSS, whereas an aggressive postoperative steroid regimen seemed to provide protection against it.
authors.affiliation: Refractive Surgery Department Centro de Especialidades Marqués de Sotelo and Hospital NISA Virgen del Consuelo, Valencia, Spain.
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Muñoz
authors.forename: César
authors.initials: C
authors.lastname: Albarrán-Diego
authors.forename: Hani F
authors.initials: HF
authors.lastname: Sakla
authors.forename: Jaime
authors.initials: J
authors.lastname: Javaloy
authors.forename: Jorge L
authors.initials: JL
authors.lastname: Alió
mesh_terms: D000328:Adult; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D020731:Keratomileusis, Laser In Situ; D008297:Male; D020795:Photophobia / Q000453:epidemiology* / Q000517:prevention & control*; D011183:Postoperative Complications; D011446:Prospective Studies; D013577:Syndrome; D014792:Visual Acuity
chemical_list: D005938:Glucocorticoids